DURECT Corporation Announces Long-Term Drug Supply Agreement With Mallinckrodt
CUPERTINO, Calif., March 27 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) announced today that it has a long-term supply agreement with Mallinckrodt, a global manufacturer and marketer of specialty medical products. Mallinckrodt will supply DURECT’s clinical and commercial requirements for sufentanil, a potent opioid analgesic and critical component of the company’s lead product DUROS sufentanil, for […]
DURECT Corporation Announces Long-Term Drug Supply Agreement With Mallinckrodt Read More »